<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04780256</url>
  </required_header>
  <id_info>
    <org_study_id>CORE 3</org_study_id>
    <nct_id>NCT04780256</nct_id>
  </id_info>
  <brief_title>Endoscopic Resection of Gastrointestinal Neoplasms</brief_title>
  <official_title>Retrospective Study of Efficacy and Safety of the Endoscopic Removal of Cancerous and Precancerous Lesions of the Upper and Lower Digestive Tract</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arcispedale Santa Maria Nuova-IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arcispedale Santa Maria Nuova-IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to retrospectively investigate the endoscopic resection procedures of&#xD;
      cancerous and precancerous lesions of the upper and lower digestive tract in order to&#xD;
      evaluate the efficacy and safety outcomes and to compare different resection techniques. In&#xD;
      particular, the resection techniques investigated will be mucosectomy, en bloc and piecemeal,&#xD;
      endoscopic submucosal dissection (ESD) and its variants, full-thickness resection. The&#xD;
      anatomical districts involved will be the esophagus, stomach, duodenum, colon and rectum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>en bloc resection rate</measure>
    <time_frame>one month</time_frame>
    <description>the en bloc resection is the ability to remove the neoplasia in a single piece</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complete resection rate</measure>
    <time_frame>one month</time_frame>
    <description>the complete resection is the ability to remove the neoplasia with clear margins (R0)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>one year</time_frame>
    <description>recurrence is the recurrence of the neoplasm at the resection site during follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse events rate</measure>
    <time_frame>one month</time_frame>
    <description>complication rate, early or late, related to the procedure used for endoscopic resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>costs</measure>
    <time_frame>one month</time_frame>
    <description>evaluation of the costs incurred to perform the endoscopic resection</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Endoscopic Mucosal Resection</condition>
  <condition>Endoscopic Submucosal Dissection</condition>
  <condition>Gastric Neoplasm</condition>
  <condition>Colonic Neoplasms</condition>
  <condition>Esophageal Neoplasms</condition>
  <condition>Duodenal Neoplasms</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic resection</intervention_name>
    <description>The endoscopic resection is the procedure that allows to remove cancerous or precancerous conditions of digestive tract. Endoscopic resection can be preformed by several techniques:&#xD;
Endoscopic mucosal resection (EMR): it allows to remove mucosal lesions&#xD;
Endoscopic submucosal dissection: it allows to remove mucosal lesions that involved submucosal layer and large lesions&#xD;
Full-thickness resection: it allows to remove infiltrating lesions by the resection of a little piece of the entire gastrointestinal wall</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients&gt; 18 years of age who have undergone endoscopic resection of cancerous or&#xD;
        pre-cancerous lesions of the digestive tract will be included in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  all patients who have undergone endoscopic resection of an upper or lower digestive&#xD;
             tract tumor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age under 18&#xD;
&#xD;
          -  inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paolo Cecinato, MD</last_name>
    <phone>+393476117414</phone>
    <email>paolo.cecinato@ausl.re.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS-AUSL Reggio Emilia</name>
      <address>
        <city>Reggio Emilia</city>
        <state>RE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Lucarini, MD</last_name>
      <email>matteo.lucarini@ausl.re.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arcispedale Santa Maria Nuova-IRCCS</investigator_affiliation>
    <investigator_full_name>Paolo Cecinato</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endoscopic mucosal resection (EMR)</keyword>
  <keyword>Endoscopic submucosal dissection (ESD)</keyword>
  <keyword>Endoscopic full thickness resection (EFTR)</keyword>
  <keyword>Colorectal ESD</keyword>
  <keyword>Colorectal EMR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Duodenal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

